Filing Details
- Accession Number:
- 0001438133-22-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-03 16:23:20
- Reporting Period:
- 2022-02-01
- Accepted Time:
- 2022-02-03 16:23:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438133 | Tandem Diabetes Care Inc | TNDM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1422126 | B David Berger | C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121 | Evp, Bus Ops & Compliance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-02-01 | 1,000 | $18.86 | 5,451 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-02-01 | 242 | $116.67 | 5,209 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-02-01 | 400 | $117.78 | 4,809 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-02-01 | 358 | $118.89 | 4,451 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Acquisiton | 2022-02-01 | 1,000 | $18.86 | 1,000 | $18.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
49,000 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 242 | Indirect | Berger Family Trust |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $116.36 to $116.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.46 to $118.12. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.52 to $119.04. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The securities are held by the Berger Family Trust dated April 16, 2008.
- The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
- The expiration date for these options is 10 years from the date of grant.